Dietary apigenin regulates high glucose and hypoxic reoxygenation-induced reductions in apelin expression in human endothelial cells

Journal of Nutritional Biochemistry

Volumn 23, Issue 8, 2012, Pages 929-936

  Yamagata, Kazuo ^a   Tagawa, Chika ^a   Matsufuji, Hiroshi ^a   Chino, Makoto ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Apelin; Apigenin; Endothelial cells; Hypoxia

Indexed keywords

APELIN; APIGENIN; FATTY ACID TRANSPORT PROTEIN 1; FATTY ACID TRANSPORTER; GLUCOSE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; EXPOSURE; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOFLUORESCENCE; PROTEIN EXPRESSION; REOXYGENATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

APIGENIN; CELL HYPOXIA; CELL LINE; DIET; ENDOTHELIAL CELLS; FATTY ACID TRANSPORT PROTEINS; GLUCOSE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; OXYGEN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84864024573     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2011.04.019     Document Type: Article

References (49)

1. Pietro L., Daher S., Rudge M.V., Calderon I.M., Damasceno D.C., Sinzato Y.K., et al. Vascular endothelial growth factor (VEGF) and VEGF-receptor expression in placenta of hyperglycemic pregnant women. Placenta 2010, 31:770-780.
2. Kidoya H., Naito H., Takakura N. Apelin induces enlarged and nonleaky blood vessels for functional recovery from ischemia. Blood 2010, 115:3166-3174.
3. Sainson R.C., Johnston D.A., Chu H.C., Holderfield M.T., Nakatsu M.N., Crampton S.P., et al. TNF primes endothelial cells for angiogenic sprouting by inducing a tip cell phenotype. Blood 2008, 111:4997-5007.
4. Chen J.X., Zeng H., Lawrence M.L., Blackwell T.S., Meyrick B. Angiopoietin-1-induced angiogenesis is modulated by endothelial NADPH oxidase. Am J Physiol Heart Circ Physiol 2006, 291:H1563-72.
5. Ushio-Fukai M. Redox signaling in angiogenesis: role of NADPH oxidase. Cardiovasc Res 2006, 71:226-235.
6. Li W., Prakash R., Kelly-Cobbs A.I., Ogbi S., Kozak A., El-Remessy A.B. Adaptive cerebral neovascularization in a model of type 2 diabetes: relevance to focal cerebral ischemia. Diabetes 2010, 59:228-235.
7. Kasai A., Shintani N., Kato H., Matsuda S., Gomi F., Haba R., et al. Retardation of retinal vascular development in apelin-deficient mice. Arterioscler Thromb Vasc Biol 2008, 28:1717-1722.
8. Zeng X.J., Zhang L.K., Wang H.X., Lu L.Q., Ma L.Q., Tang C.S. Apelin protects heart against ischemia/reperfusion injury in rat. Peptides 2009, 30:1144-1152.
9. Graf B.A., Milbury P.E., Blumberg J.B. Flavonols, flavones, flavanones, and human health: epidemiological evidence. J Med Food 2005, 8:281-290.
10. Leifert W.R., Abeywardena M.Y. Cardioprotective actions of grape polyphenols. Nutr Res 2008, 28:729-737.
11. Osada M., Imaoka S., Funae Y. Apigenin suppresses the expression of VEGF, an important factor for angiogenesis, in endothelial cells via degradation of HIF-1alpha protein. FEBS Lett 2004, 575:59-63.
12. Kim J.A., Formoso G., Li Y., Potenza M.A., Marasciulo F.L., Montagnani M., et al. Epigallocatechin gallate, a green tea polyphenol, mediates NO-dependent vasodilation using signaling pathways in vascular endothelium requiring reactive oxygen species and Fyn. J Biol Chem 2007, 282:13736-13745.
13. Oak M.H., El Bedoui J., Schini-Kerth V.B. Antiangiogenic properties of natural polyphenols from red wine and green tea. J Nutr Biochem 2005, 16:1-8.
14. Gimeno R.E. Fatty acid transport proteins. Curr Opin Lipidol 2007, 18:271-276.
15. Garcia-Martinez C., Marotta M., Moore-Carrasco R., Guitart M., Camps M., Busquets S., et al. Impact on fatty acid metabolism and differential localization of FATP1 and FAT/CD36 proteins delivered in cultured human muscle cells. Am J Physiol Cell Physiol 2005, 288:C1264-72.
16. Van der Vusse G.J., Glatz J.F., Van Nieuwenhoven F.A., Reneman R.S., Bassingthwaighte J.B. Transport of long-chain fatty acids across the muscular endothelium. Adv Exp Med Biol 1998, 441:181-191.
17. Hagberg C.E., Falkevall A., Wang X., Larsson E., Huusko J., Nilsson I., et al. Vascular endothelial growth factor B controls endothelial fatty acid uptake. Nature 2010, 464:917-921.
18. Masuzawa M., Fujimura T., Hamada Y., Fujita Y., Hara H., Nishiyama S., et al. Establishment of a human hemangiosarcoma cell line (ISO-HAS). Int J Cancer 1999, 81:305-308.
19. Krump-Konvalinkova V., Yasuda S., Rubic T., Makarova N., Mages J., Erl W., et al. Stable knock-down of the sphingosine 1-phosphate receptor S1P1 influences multiple functions of human endothelial cells. Arterioscler Thromb Vasc Biol 2005, 25:546-552.
20. Amo Y., Masuzawa M., Hamada Y., Katsuoka K. Expression of vascular endothelial growth factor in a human hemangiosarcoma cell line (ISO-HAS). Arch Dermatol Res 2001, 293:296-301.
21. Unger R.E., Krump-Konvalinkova V., Peters K., Kirkpatrick C.J., et al. In vitro expression of the endothelial phenotype: comparative study of primary isolated cells and cell lines, including the novel cell line HPMEC-ST1.6R. Microvasc Res 2002, 64:384-397.
22. Yamagata K., Ichinose S., Miyashita A., Tagami M. Protective effects of ebselen, a seleno-organic antioxidant on neurodegeneration induced by hypoxia and reperfusion in stroke-prone spontaneously hypertensive rat. Neuroscience 2008, 153:428-435.
23. Yamagata K., Miyashita A., Matsufuji H., Chino M. Dietary flavonoid apigenin inhibits high glucose and tumor necrosis factor alpha-induced adhesion molecule expression in human endothelial cells. J Nutr Biochem 2010, 21:116-124.
24. Kuusisto J., Mykkanen L., Pyorala K., Laakso M. NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 1994, 43:960-967.
25. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Eng J Med 1993, 329:977-986. The Diabetes Control, and Complications Trial Research Group.
26. Lash J.M., Nase G.P., Bohlen H.G. Acute hyperglycemia depresses arteriolar NO formation in skeletal muscle. Am J Physiol 1999, 277:H1513-20.
27. Tesfamariam B., Brown M.L., Deykin D., Cohen R.A. Elevated glucose promotes generation of endothelium-derived vasoconstrictor prostanoids in rabbit aorta. J Clin Invest 1990, 85:929-932.
28. Su Y., Liu X.M., Sun Y.M., Wang Y.Y., Luan Y., Wu Y. Endothelial dysfunction in impaired fasting glycemia, impaired glucose tolerance, and type 2 diabetes mellitus. Am J Cardiol 2008, 102:497-498.
29. Nabel E.G. Biology of the impaired endothelium. Am J Cardiol 1991, 68:6C-8C.
30. Kasai A., Shintani N., Oda M., Kakuda M., Hashimoto H., Matsuda T., et al. Apelin is a novel angiogenic factor in retinal endothelial cells. Biochem Biophys Res Commun 2004, 325:395-400.
31. Kidoya H., Ueno M., Yamada Y., Mochizuki N., Nakata M., Yano T., et al. Spatial and temporal role of the apelin/APJ system in the caliber size regulation of blood vessels during angiogenesis. EMBO J 2008, 27:522-534.
32. Cox C.M., D'Agostino S.L., Miller M.K., Heimark R.L., Krieg P.A. Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo. Dev Biol 2006, 296:177-189.
33. Singh H., Brindle N.P., Zammit V.A. High glucose and elevated fatty acids suppress signaling by the endothelium protective ligand angiopoietin-1. Microvasc Res 2010, 79:121-127.
34. Han S., Wang G., Qi X., Lee H.M., Englander E.W., Greeley G.H. A possible role for hypoxia-induced apelin expression in enteric cell proliferation. Am J Physiol Regu Integr Comp Physiol 2008, 294:R1832-39.
35. Allen D.A., Yaqoob M.M., Harwood S.M. Mechanisms of high glucose-induced apoptosis and its relationship to diabetic complications. J Nutr Biochem 2005, 16:705-713.
36. Carden D.L., Granger D.N. Pathophysiology of ischaemia-reperfusion injury. J Pathol 2000, 190:255-266.
37. Risau W. Mechanisms of angiogenesis. Nature 1997, 386:671-674.
38. Poole T.J., Finkelstein E.B., Cox C.M. The role of FGF and VEGF in angioblast induction and migration during vascular development. Dev Dyn 2001, 220:1-17.
39. Matsunaga S., Okigaki M., Takeda M., Matsui A., Honsho S., Katsume A., et al. Endothelium-targeted overexpression of constitutively active FGF receptor induces cardioprotection in mice myocardial infarction. J Mol Cell Cardiol 2009, 46:663-673.
40. Lelkes P.I., Hahn K.L., Sukovich D.A., Karmiol S., Schmidt D.H. On the possible role of reactive oxygen species in angiogenesis. Adv Exp Med Biol 1998, 454:295-310.
41. Maulik N., Das D.K. Redox signaling in vascular angiogenesis. Free Radic Biol Med 2002, 33:1047-1060.
42. Hori M., Nishida K. Oxidative stress and left ventricular remodelling after myocardial infarction. Cardiovasc Res 2009, 81:457-464.
43. Shono T., Ono M., Izumi H., Jimi S.I., Matsushima K., Okamoto T., et al. Involvement of the transcription factor NF-kappaB in tubular morphogenesis of human microvascular endothelial cells by oxidative stress. Mol Cell Biol 1996, 16:4231-4239.
44. Jin B.H., Qian L.B., Chen S., Li J., Wang H.P., Bruce I.C., Lin J., Xia Q. Apigenin protects endothelium-dependent relaxation of rat aorta against oxidative stress. Eur J Pharmacol 2009, 616:200-205.
45. Zou Y., Chiou G.C. Apigenin inhibits laser-induced choroidal neovascularization and regulates endothelial cell function. J Ocul Pharmacol Ther 2006, 22:425-430.
46. Wang Y., Chang J., Li Y.S., Chien S. Shear stress and VEGF activate IKK via the Flk-1/Cbl/Akt signaling pathway. Am J Physiolol-Heart and Circ Physiol 2004, 286:H685-92.
47. Lee Y.K., Bone N.D., Strege A.K., Shanafelt T.D., Jelinek D.F., Kay N.E. VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemia. Blood 2004, 104:788-794.
48. Fukuda S., Kaga S., Zhan L., Bagchi D., Das D.K., Bertelli A., et al. Resveratrol ameliorates myocardial damage by inducing vascular endothelial growth factor-angiogenesis and tyrosine kinase receptor Flk-1. Cell Biochem Biophs 2006, 44:43-49.
49. Sorli S.C., Le Gonidec S., Knibiehler B., Audigier Y. Apelin is a potent activator of tumour neoangiogenesis. Oncogene 2007, 26:7692-7699.